by GlobeNewsWire | Dec 2, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Dec. 02, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
by GlobeNewsWire | Nov 30, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
by editor | Nov 23, 2015 | Buzz, Feature Box
The Buzz is picking up big time for Anavex Life Sciences (Nasdaq: AVXL), as the stock begins to move up after recent highs of over $14. Let’s look at this Buzz![cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]Bringing the Elections into the...
by GlobeNewsWire | Nov 18, 2015 | Globe Newswire
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]NEW YORK, Nov. 18, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat...
by GlobeNewsWire | Nov 5, 2015 | Globe Newswire
NEW YORK, Nov. 05, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases,...
